Thrombosis
Conference Coverage
Drinking beet juice tied to reduced post-PCI restenosis
Dietary nitrate in the form of beet juice reduced restenosis after percutaneous interventions in a randomized trial.
Latest News
No advantage for full-term aspirin in preventing preterm preeclampsia
However, editorialists wrote that the questions surrounding continuing or discontinuing aspirin in a high-risk population need further...
Guidelines
New ACC, AHA, SCAI interventional cardiology training guidance
The document provides a roadmap for program directors and interventional cardiology trainees to help them progress through important training...
Conference Coverage
Novel celery seed–derived drug may improve stroke outcomes
Patients treated with butylphthalide had fewer severe neurologic symptoms and better function 90 days after the stroke, compared with those...
From the Journals
Cardiac issues twice as likely with COVID plus high troponin
Hospitalized COVID-19 patients with high troponin levels were twice as likely to have cardiac abnormalities due to diverse causes in a large U.K....
Conference Coverage
STROKE AF at 3 years: High AFib rate after atherosclerotic stroke
Continuous monitoring to detect AFib should be considered in a larger population of stroke patients rather than just those with cryptogenic stroke...
Commentary
Universal testing for Lp(a): What are we waiting for?
A resurgent interest in molecular pathophysiology this past decade has clarified Lp(a)’s unique contribution to atherothrombotic disease and...
From the Journals
After PCI, 1-month beats 12-month DAPT in high-risk patients
When dual was replaced by single antiplatelet therapy 1 month after PCI in Japanese patients, bleeding risk declined.
Latest News
Warfarin best for thrombotic antiphospholipid syndrome?
A vitamin K antagonist such as warfarin, rather than a direct oral anticoagulant, appears to be a better treatment for patients with thrombotic...
From the Journals
Statins tied to lower ICH risk regardless of bleed location
A large new case-control study has shown a reduced risk of both lobar and nonlobar intracerebral hemorrhage with statin use, providing reassurance...
Conference Coverage
No benefit of rivaroxaban in COVID outpatients: PREVENT-HD
PREVENT-HD joins a long list of smaller trials also showing no benefit of anticoagulation in nonhospitalized COVID-19 patients.